Cogent Biosciences, Inc. COGT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s total assets?
- Cogent Biosciences, Inc. (COGT) reported total assets of $903.01M in Q1 2026.
- How has Cogent Biosciences, Inc.'s total assets changed year-over-year?
- Cogent Biosciences, Inc.'s total assets increased by 218.2% year-over-year, from $283.8M to $903.01M.
- What is the long-term trend for Cogent Biosciences, Inc.'s total assets?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s total assets has grown at a 30.2% compound annual growth rate (CAGR), from $250.92M to $937.61M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.